1. Home
  2. SCWO vs ANEB Comparison

SCWO vs ANEB Comparison

Compare SCWO & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 374Water Inc.

SCWO

374Water Inc.

HOLD

Current Price

$3.15

Market Cap

54.2M

Sector

Utilities

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

N/A

Current Price

$1.07

Market Cap

46.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCWO
ANEB
Founded
2021
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.2M
46.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SCWO
ANEB
Price
$3.15
$1.07
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
156.1K
55.3K
Earning Date
11-12-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,910,340.00
N/A
Revenue This Year
$5,945.19
N/A
Revenue Next Year
$106.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
508.52
N/A
52 Week Low
$1.63
$0.80
52 Week High
$10.90
$3.42

Technical Indicators

Market Signals
Indicator
SCWO
ANEB
Relative Strength Index (RSI) 66.92 38.82
Support Level $2.93 $0.80
Resistance Level $3.50 $1.12
Average True Range (ATR) 0.32 0.09
MACD -0.01 0.03
Stochastic Oscillator 65.69 72.83

Price Performance

Historical Comparison
SCWO
ANEB

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: